Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 2;16(1):1175-1181.
doi: 10.1515/biol-2021-0117. eCollection 2021.

miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R

Yunjiang Wang  1 , Jia Du  2
Affiliations

miR-378a-3p regulates glioma cell chemosensitivity to cisplatin through IGF1R

Yunjiang Wang et al. Open Life Sci. .

Abstract

Glioma is a type of common intracranial tumor. In this study, we investigated the molecular mechanism by which miR-378a-3p regulates cisplatin (CDDP) chemosensitivity in glioma cells via insulin-like growth factor 1 receptor (IGF1R). U251/CDDP cells were treated with CDDP and transfected with miR-378a-3p mimics, NC mimics, or pcDNA-IGF1R. qRT-PCR was used to measure the differential level of miR-378a-3p. CCK-8 assay was used to test cell proliferation, and flow cytometry was used to analyze apoptosis. The targeting relationship between miR-378a-3p and IGF1R was tested through a dual-luciferase reporter gene assay. In contrast to normal glial cells, the miR-378a-3p level decreased in human glioma U251 cells and had lower expression in U251/CDDP cells. Compared with the CDDP group, miR-378a-3p significantly caused the inhibition of U251/CDDP cell proliferation and enhanced apoptosis in the miR-378a-3p mimics + CDDP group. Another experiment confirmed that IGF1R was a target gene of miR-378a-3p, and overexpression of miR-378a-3p inhibited IGF1R expression. In addition, co-overexpression of miR-378a-3p and IGF1R induced the upregulation of the U251/CDDP cell proliferation and the inhibition of apoptosis in the miR-378a-3p mimics + pcDNA-IGF1R + CDDP group. This study confirmed that miR-378a-3p promoted the sensitivity of glioma cells to CDDP in glioma patients via targeting IGF1R to increase the therapeutic effect during chemotherapy.

Keywords: chemosensitivity; cisplatin; glioma; insulin like growth factor 1 receptor; miR-378a-3p.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors state no conflict of interest.

Figures

Figure 1
Figure 1
Expression of miR-378a-3p in drug-resistant U251/CDDP cells. (a) miR-378a-3p expression was detected by qRT-PCR. (b) Dose–response curve of CDDP administration on glioma cells was detected by the CCK-8 assay. ** p < 0.01.
Figure 2
Figure 2
Effects of miR-378a-3p on the chemosensitivity of CDDP/U251 cells. (a) qRT-PCR assay was used to validate miR-378a-3p transfection efficiency. (b) Dose–effect curve of CDDP administration on glioma cells after transfection of miR-378a-3p/NC mimics in U251 cells. (c) The proliferation of U251/CDDP cells was detected by the CCK-8 assay. (d) The apoptosis of U251/CDDP cells was detected by flow cytometry. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Figure 3
Figure 3
miR-378a-3p directly targets IGF1R. (a) Binding sequences between miR-378a-3p and IGF1R. (b) Dual luciferase reporter assay was used to detect the binding relationship between miR-378a-3p and IGF1R. (c) Western blotting was used to detect the protein expressions. ** p < 0.01 and *** p < 0.001.
Figure 4
Figure 4
miR-378a-3p promotes the sensitivity of CDDP/U251 cells by regulating IGF1R. (a) IGF1R protein expression was detected by Western blotting. (b) Cell proliferation was detected by the CCK-8 assay. (c) Cell apoptosis was detected by Annexin V-FITC/PI and flow cytometry. *** p < 0.001.
See this image and copyright information in PMC

References

    1. Huang MH, Huang YM, Wu SN. The inhibition by oxaliplatin, a platinum-based anti-neoplastic agent, of the activity of intermediate-conductance Ca²⁺-activated K⁺ channels in human glioma cells. Cell Physiol Biochem. 2015;37(4):1390–406. 10.1159/000430404. PMID: 26488725. - DOI - PubMed
    2. Huang MH, Huang YM, Wu SN. The inhibition by oxaliplatin, a platinum-based anti-neoplastic agent, of the activity of intermediate-conductance Ca²⁺-activated K⁺ channels in human glioma cells. Cell Physiol Biochem. 2015;37(4):1390–406. doi: 10.1159/000430404. PMID: 26488725. - DOI - PubMed
    1. Dhawan S, Patil CG, Chen C, Venteicher AS. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev. 2020;1(1):Cd009229. 10.1002/14651858.CD009229.pub3. PMID: 31958162. - DOI - PMC - PubMed
    2. Dhawan S, Patil CG, Chen C, Venteicher AS. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev. 2020;1(1):Cd009229. doi: 10.1002/14651858.CD009229.pub3. PMID: 31958162. - DOI - PMC - PubMed
    1. Abdellatief SA, Galal AA, Farouk SM, Abdel-Daim MM. Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: a biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother. 2017;86:482–91. 10.1016/j.biopha.2016.12.038. PMID: 28012928. - DOI - PubMed
    2. Abdellatief SA, Galal AA, Farouk SM, Abdel-Daim MM. Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: a biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother. 2017;86:482–91. doi: 10.1016/j.biopha.2016.12.038. PMID: 28012928. - DOI - PubMed
    1. Abdel-Daim MM, Mahmoud OM, Al Badawi MH, Alghamdi J, Alkahtani S, Salem NA. Protective effects of Citrus limonia oil against cisplatin-induced nephrotoxicity. Env Sci Pollut Res Int. 2020;27(33):41540–50. 10.1007/s11356-020-10066-x. PMID: 32691312. - DOI - PubMed
    2. Abdel-Daim MM, Mahmoud OM, Al Badawi MH, Alghamdi J, Alkahtani S, Salem NA. Protective effects of Citrus limonia oil against cisplatin-induced nephrotoxicity. Env Sci Pollut Res Int. 2020;27(33):41540–50. doi: 10.1007/s11356-020-10066-x. PMID: 32691312. - DOI - PubMed
    1. Wu S, Zhang R, Nie F, Wang X, Jiang C, Liu M, et al. MicroRNA-137 Inhibits EFNB2 expression affected by a genetic variant and is expressed aberrantly in peripheral blood of schizophrenia patients. EBioMedicine. 2016;12:133–42. 10.1016/j.ebiom.2016.09.012. PMID: 27650867. - DOI - PMC - PubMed
    2. Wu S, Zhang R, Nie F, Wang X, Jiang C, Liu M. et al. MicroRNA-137 Inhibits EFNB2 expression affected by a genetic variant and is expressed aberrantly in peripheral blood of schizophrenia patients. EBioMedicine. 2016;12:133–42. doi: 10.1016/j.ebiom.2016.09.012. PMID: 27650867. - DOI - PMC - PubMed

LinkOut - more resources